BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,403,000 | -23.4% | 1,057,512 | +11.9% | 0.00% | -25.0% |
| Q3 2016 | $18,810,000 | +64.3% | 945,216 | +7.0% | 0.00% | +33.3% |
| Q2 2016 | $11,446,000 | +119.4% | 883,201 | +58.3% | 0.00% | +200.0% |
| Q1 2016 | $5,216,000 | -51.9% | 557,813 | +4.2% | 0.00% | -66.7% |
| Q4 2015 | $10,850,000 | +237.1% | 535,292 | +141.6% | 0.00% | +200.0% |
| Q3 2015 | $3,219,000 | -31.5% | 221,543 | +0.3% | 0.00% | 0.0% |
| Q2 2015 | $4,698,000 | -13.4% | 220,886 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $5,422,000 | – | 234,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |